Watchlist Price Alert

Cardio Diagnostics Inc. (CDIO)

NASDAQ: CDIO · Real-Time Price · USD

3.92

-0.03 (-0.76%)

At close: Jun 17, 2025, 10:38 AM

-0.76% (1D)

Bid	3.84
Market Cap	6.82M
Revenue (ttm)	19.9K
Net Income (ttm)	-5.85M
EPS (ttm)	-4.05
PE Ratio (ttm)	-0.97
Forward PE	-0.24
Analyst	Hold

Ask	4
Volume	2,654
Avg. Volume (20D)	58,426
Open	3.94
Previous Close	3.95
Day's Range	3.81 - 4.00
52-Week Range	3.40 - 53.10
Beta	3.06

About CDIO

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol CDIO

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CDIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 month ago

-47.09%

Cardio Diagnostics Holdings shares are trading low... Unlock content with Pro Subscription

News

6 days ago · businesswire.com

Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics announced that the Japan Patent Office has issued a patent for another set of biomarkers in the company's IP portfolio.

2 weeks ago · businesswire.com

Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics today announced it has regained compliance with Nasdaq minimum bid price.

3 weeks ago · businesswire.com

Cardio Diagnostics Broadens Access to Precision Cardiovascular Care with New Practice Partnerships Across U.S. Mainland and Puerto Rico

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics has the continued expansion of its reach with a new cohort of healthcare practices across the United States.

1 month ago · businesswire.com

Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings today announced a 1-for-30 reverse stock split of its common stock effective with the market opening on May 13, 2025.

2 months ago · businesswire.com

Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology's 74th Annual Scientific Session

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will showcase its growing portfolio of advanced cardiovascular solutions at the ACC's 74th Annual Scientific Session & Expo.